Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar. The injections, as well as the side effects from both regimens, can be ...
Biochemistry
May 31, 2017
0
12
Treatment for certain diabetes cases involves constant monitoring of blood-glucose levels and daily insulin shots. But scientists are now developing a painless "smart" patch that monitors blood glucose and releases insulin ...
Bio & Medicine
Jan 18, 2017
0
10
Gene variants associated with disease are typically considered faulty; problems arise when the proteins they make don't adequately carry out their designated role. But a new biochemical study from Johns Hopkins researchers ...
Biochemistry
Dec 15, 2016
0
16
For several years, scientists have been working toward "breathalyzers" that can diagnose various diseases without painful pinpricks, needles or other unpleasant methods. Now, one team has developed a new, portable breath ...
Analytical Chemistry
Nov 9, 2016
0
5
Type 1 diabetes patients may one day be able to monitor their blood glucose levels and even control their insulin infusions via a transparent sensor on a contact lens, a new Oregon State University study suggests.
Nanophysics
Nov 2, 2016
0
537
Some of the world's most important discoveries – penicillin, vulcanized rubber and Velcro, to name a few – were made by accident. In fact, it's been said that upward of half of all scientific discoveries are by chance.
Bio & Medicine
Aug 12, 2016
1
26
The potential to use a patient's own cells to treat non-healing chronic wounds - a serious complication of diabetes - took an important step forward as researchers successfully reprogrammed skin cells taken from diabetic ...
Cell & Microbiology
Aug 10, 2016
0
5
Researchers have developed a light-activated tool to show how drugs need to be adapted to combat type 2 diabetes.
Biochemistry
Apr 11, 2016
1
30
New research from the University of Copenhagen points to an entirely new approach for designing insulin-based pharmaceuticals. The approach could open the door for more personalized medications with fewer side effects for ...
Biochemistry
Feb 18, 2016
0
26
The protein targets of a class of 'blockbuster' diabetes drugs have been identified by A*STAR researchers and may help explain varying type-2 patient responses to the drugs.
Biochemistry
Jan 6, 2016
0
8
